What is the latest BIOCON stock price?
The latest stored price for BIOCON is Rs 362.20 as of 2026-11-16.
BIOCON LIMITED. is a mid-cap stock in Healthcare. This Gimli page shows the latest available BIOCON price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
The latest stored price for BIOCON is Rs 362.20 as of 2026-11-16.
BIOCON is below 50DMA, below 200DMA. The latest 50DMA is 366.39 and the latest 200DMA is 390.05.
BIOCON has PE 172.35, ROE +1.06%, and ROCE +2.56% in Gimli's latest available snapshot.
BIOCON has returned +3.72% over 1 month, -13.14% over 3 months, and -11.91% over 12 months in the latest stored data.
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-09-30 | 4,345.00 cr | 858.70 cr | 56.70 cr | 0.25 |
| 2026-06-30 | 689.30 cr | 125.60 cr | 136.80 cr | 0.87 |
| 2026-03-31 | 4,484.30 cr | 992.40 cr | 198.60 cr | 0.79 |
| 2025-12-31 | 4,173.00 cr | 657.40 cr | -51.80 cr | 1.08 |
| 2025-09-30 | 4,262.50 cr | 916.50 cr | 132.80 cr | 0.66 |
| 2025-06-30 | 3,910.10 cr | 828.60 cr | 31.40 cr | 0.26 |
| 2025-03-31 | 4,358.10 cr | 1,135.50 cr | 344.50 cr | 2.88 |
| 2024-12-31 | 3,773.00 cr | 804.70 cr | 25.10 cr | 0.21 |
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 16,779.90 cr | 3,394.90 cr | 385.60 cr | 2.82 |
| 2025-03-31 | 15,052.20 cr | 4,471.00 cr | 1,013.30 cr | 8.46 |
| 2024-03-31 | 14,195.80 cr | 4,068.40 cr | 1,022.50 cr | 8.55 |
| 2023-03-31 | 10,934.10 cr | 2,429.20 cr | 462.70 cr | 3.88 |
| 2022-03-31 | 1,925.40 cr | 1,864.90 cr | 86.10 cr | 0.72 |
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 63,650.60 cr | 2,416.50 cr | 15,434.10 cr | 36,621.50 cr |
| 2025-03-31 | 58,797.30 cr | 3,226.70 cr | 18,362.00 cr | 27,712.50 cr |
| 2024-03-31 | 56,070.70 cr | 1,233.40 cr | 16,276.70 cr | 25,274.80 cr |
| 2023-03-31 | 52,042.80 cr | 1,323.20 cr | 18,018.80 cr | 22,488.80 cr |
| 2022-03-31 | 20,394.00 cr | 662.60 cr | 5,146.60 cr | 9,470.00 cr |
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 1,994.00 cr | 82.30 cr | n/a |
| 2025-03-31 | 4,061.20 cr | 1,717.90 cr | n/a |
| 2024-03-31 | 2,953.90 cr | 1,022.30 cr | n/a |
| 2023-03-31 | 1,852.50 cr | 126.20 cr | n/a |
| 2022-03-31 | 1,176.60 cr | -748.20 cr | n/a |
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-09-30 | +44.68% | +8.64% | +29.30% | +22.08% | +17.20% | +0.00% |
| 2026-06-30 | +44.68% | +8.14% | +23.38% | +15.47% | +23.75% | +0.00% |
| 2026-06-29 | +44.68% | +8.16% | +23.37% | +15.49% | +23.74% | +0.00% |
| 2026-03-31 | +44.91% | +7.52% | +24.07% | +16.53% | +23.41% | +0.00% |
| 2026-01-14 | +44.91% | +7.14% | +24.16% | +17.03% | +23.69% | +0.00% |
| 2026-01-05 | +48.27% | +6.56% | +19.65% | +12.17% | +25.42% | +0.00% |
| 2025-12-31 | +54.45% | +7.39% | +21.71% | +13.75% | +16.33% | +0.00% |
| 2025-09-30 | +54.45% | +6.61% | +22.10% | +14.13% | +16.69% | +0.00% |
| 2025-06-30 | +54.45% | +6.04% | +22.82% | +15.24% | +16.50% | +0.00% |
| 2025-06-19 | +54.45% | +7.00% | +21.45% | +13.82% | +16.91% | +0.00% |
| 2025-03-31 | +60.64% | +5.66% | +15.72% | +8.77% | +17.76% | +0.00% |
| 2024-12-31 | +60.64% | +5.66% | +15.37% | +8.58% | +18.12% | +0.00% |
| 2024-09-30 | +60.64% | +5.93% | +14.44% | +7.97% | +18.75% | +0.00% |
| 2024-06-30 | +60.64% | +5.90% | +14.30% | +8.69% | +18.89% | +0.00% |
| 2024-03-31 | +60.64% | +5.63% | +13.68% | +8.57% | +19.73% | +0.00% |
| 2023-12-31 | +60.64% | +6.55% | +14.51% | +9.31% | +17.96% | +0.00% |
| 2023-09-30 | +60.64% | +7.96% | +14.08% | +8.26% | +16.92% | +0.00% |
| 2023-06-30 | +60.64% | +9.52% | +12.59% | +7.47% | +16.76% | +0.00% |
| 2023-03-31 | +60.64% | +10.20% | +11.90% | +7.19% | +16.71% | +0.00% |
| 2022-12-31 | +60.64% | +14.42% | +8.63% | +3.95% | +15.73% | +0.00% |
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 448,075.81 cr | 40.781879 | +14.03% | +6.28% |
| DIVISLAB | DIVI S LABORATORIES LTD | 294,139.21 cr | 87.463339 | +21.13% | +70.16% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 178,438.17 cr | 85.011038 | +16.67% | +22.43% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 126,113.56 cr | 53.952325 | +24.95% | +18.20% |
| LAURUSLABS | LAURUS LABS LIMITED | 119,848.17 cr | 89.960566 | +26.71% | +122.22% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 118,902.46 cr | 27.636309 | +15.44% | +26.21% |
| DRREDDY | DR. REDDY S LABORATORIES | 114,723.24 cr | 41.579949 | +7.80% | +10.59% |
| CIPLA | CIPLA LTD | 112,647.78 cr | 39.472630 | +8.80% | -8.98% |
Data snapshot: 2026-11-16. Not investment advice.